Logo

Empire Genomics Licenses Affy's Microarray Patents for Dx Development

Sep 07, 2007
NEW YORK (GenomeWeb News) — Affymetrix has licensed several of its microarray-related patents to Empire Genomics, Affy said today.
 
Under the non-exclusive agreement, Empire Genomics, a Buffalo, NY-based molecular diagnostics company, will use Affy’s technology to manufacture, use, and sell DNA chips and related products and services for comparative genomic hybridization, Affy said.
  
Financial terms of the agreement were not released.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.